Drawing for MARENGO

USPTO serial 97111780

MARENGO

Reviewed by CopyMark Law Group

Reg. 8078738Status 700Registered
Filing date
Status date
Registration date
Dec 23, 2025
Examiner
SHOOR, AMIT KUMAR
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MARENGO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Aaron D. Hendelman

Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI650 PAGE MILL ROADPALO ALTO, CA 94304-1050United States

Goods and services

ClassDescriptionStatusFirst use
042Medical and scientific research in the fields of immunology and oncology; pharmaceutical research and development; medical and scientific research, namely, conducting clinical trials for others; research and development services in the field of antibodies; research and development in immunology for the purpose of using antibodies to target malignant solid tumors and to promote protective tumor immunity; research and development in pharmacology for the purpose of triggering cytokine release for the expansion of an antigen-specific memory T cell repertoire for the purpose of treating cancer; medical research services in the field of cancer; medical and scientific research in the field of cancer treatment; medical and scientific research for immune system activation and protection; research and development for the purpose of anti-cancer immune activation therapeutics; medical and scientific research in the fields of immunology and oncology for treating cancer, infectious disease, auto-immune disease, and other diseases in connection with immune system dysfunction; research and development of vaccines and medicinesACTIVEAug 1, 2022

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 23, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 23, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 4, 2025SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Dec 4, 2025CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Nov 13, 2025SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Nov 12, 2025IUAFUSE AMENDMENT FILED—
Nov 12, 2025EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 25, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 24, 2025EX5GSOU EXTENSION 5 GRANTED—
Apr 16, 2025EXT5SOU EXTENSION 5 FILED—
Apr 16, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 23, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 22, 2025EX4GSOU EXTENSION 4 GRANTED—
Jan 15, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 14, 2024EXT4SOU EXTENSION 4 FILED—
Nov 14, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 4, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 3, 2024EX3GSOU EXTENSION 3 GRANTED—
May 3, 2024EXT3SOU EXTENSION 3 FILED—
May 3, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 19, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 17, 2023EX2GSOU EXTENSION 2 GRANTED—
Oct 17, 2023EXT2SOU EXTENSION 2 FILED—
Oct 17, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 17, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 15, 2023EX1GSOU EXTENSION 1 GRANTED—
May 15, 2023EXT1SOU EXTENSION 1 FILED—
May 15, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 21, 2023DOCKASSIGNED TO EXAMINER—
Nov 15, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 20, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 20, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 31, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 16, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 16, 2022DOCKASSIGNED TO EXAMINER—
Nov 16, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 9, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance